EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical Utility of Carotid Intima–Media Thickness Measurement in Primary Care: A Narrative Review

Jongwoo Kim

Journal of Neurosonology and Neuroimaging · 30.06.2026 · 18 (1) · 1-15

DOI: 10.31728/jnn.2026.00183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurosonology and Neuroimaging, erschienen am 30.06.2026. Verfasst von Jongwoo Kim. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carotid intima–media thickness (CIMT) is a non-invasive imaging biomarker of subclinical atherosclerosis quantified on high-resolution B-mode ultrasound. Since the seminal pathology–ultrasound correlation by Pignoli et al. in 1986, CIMT has been studied extensively as a predictor of cardiovascular events. Large prospective cohorts—including the Atherosclerosis Risk in Communities study, the Cardiovascular Health Study, the Rotterdam Study, the Kuopio Ischaemic Heart Disease Risk Factor Study, and the Multi-Ethnic Study of Atherosclerosis—have shown that CIMT predicts coronary and cerebrovascular events independently of conventional risk factors. However, the 2012 USE-IMT (Carotid Intima Media Thickness and IMT-progression as Predictors of Vascular Events) meta-analysis demonstrated that adding mean CIMT to the Framingham risk score improved the net reclassification index by only 0.8%. Current guidelines therefore do not endorse universal CIMT screening in asymptomatic adults. Nevertheless, the technique remains attractive in primary care: it avoids ionising radiation, is inexpensive, and provides simultaneous information on plaque and stenosis. Its incremental value is greatest in intermediate-risk individuals and in populations with accelerated atherosclerosis. This narrative review summarises, for the primary care physician, the pathophysiological basis of CIMT, the standardised Mannheim and American Society of Echocardiography measurement protocols, and reference distributions including representative Korean values. We propose a five-tier interpretive framework based on percentile and plaque status, and link each tier to specific pharmacological, lifestyle, and follow-up recommendations. The framework and proposed follow-up intervals are author-derived integrations of existing evidence and have not been validated in prospective trials. Emerging artificial-intelligence–based automated measurement and multimodal risk integration are also discussed.

Zitieren

APA

Kim, J. (2026). Clinical Utility of Carotid Intima–Media Thickness Measurement in Primary Care: A Narrative Review. Journal of Neurosonology and Neuroimaging, 18(1), 1-15. https://doi.org/10.31728/jnn.2026.00183

Vancouver

Kim J. Clinical Utility of Carotid Intima–Media Thickness Measurement in Primary Care: A Narrative Review. Journal of Neurosonology and Neuroimaging. 2026;18(1):1-15. doi:10.31728/jnn.2026.00183

BibTeX
@article{Kim2026,
  author = {Kim, Jongwoo},
  title = {Clinical Utility of Carotid Intima–Media Thickness Measurement in Primary Care: A Narrative Review},
  journal = {Journal of Neurosonology and Neuroimaging},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {1--15},
  doi = {10.31728/jnn.2026.00183}
}
Kostenlos starten →